Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
Tsimberidou AM, McLaughlin P, Younes A, Rodriguez MA, Hagemeister FB, Sarris A, Romaguera J, Hess M, Smith TL, Yang Y, Ayala A, Preti A, Lee MS, Cabanillas F. Tsimberidou AM, et al. Among authors: preti a. Blood. 2002 Dec 15;100(13):4351-7. doi: 10.1182/blood-2001-12-0269. Epub 2002 Aug 8. Blood. 2002. PMID: 12393618 Free article. Clinical Trial.
Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously untreated patients.
Romaguera JE, Rodríguez Díaz-Pavon J, Carías L, Hagemeister FB, McLaughlin P, Rodríguez MA, Sarris AH, Younes A, Preti A, Bachier C, Llerena E, Cabanillas F. Romaguera JE, et al. Among authors: preti a. Leuk Lymphoma. 1998 Jan;28(3-4):295-306. doi: 10.3109/10428199809092685. Leuk Lymphoma. 1998. PMID: 9517501
Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination.
Romaguera JE, Rodriguez MA, Hagemeister FB, McLaughlin P, Rodriguez J, Preti A, Younes A, Sarris AH, Cabanillas F. Romaguera JE, et al. Among authors: preti a. Invest New Drugs. 1999;17(2):187-92. doi: 10.1023/a:1006383503022. Invest New Drugs. 1999. PMID: 10638491 Clinical Trial.
Paclitaxel (Taxol) for the treatment of lymphoma.
Younes A, Ayoub JP, Sarris A, North L, Pate O, McLaughlin P, Rodriguez MA, Romaguera J, Hagemeister F, Bachier C, Preti A, Cabanillas F. Younes A, et al. Among authors: preti a. Ann Oncol. 1997;8 Suppl 1:129-31. Ann Oncol. 1997. PMID: 9187446 Clinical Trial.
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival.
Sarris AH, Kliche KO, Pethambaram P, Preti A, Tucker S, Jackow C, Messina O, Pugh W, Hagemeister FB, McLaughlin P, Rodriguez MA, Romaguera J, Fritsche H, Witzig T, Duvic M, Andreeff M, Cabanillas F. Sarris AH, et al. Among authors: preti a. Ann Oncol. 1999 Apr;10(4):433-40. doi: 10.1023/a:1008301602785. Ann Oncol. 1999. PMID: 10370786 Free article. Clinical Trial.
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
Popat U, Przepiork D, Champlin R, Pugh W, Amin K, Mehra R, Rodriguez J, Giralt S, Romaguera J, Rodriguez A, Preti A, Andersson B, Khouri I, Claxton D, de Lima M, Donato M, Anderlini P, Gajewski J, Cabanillas F, van Besien K. Popat U, et al. Among authors: preti a. J Clin Oncol. 1998 Jan;16(1):63-9. doi: 10.1200/JCO.1998.16.1.63. J Clin Oncol. 1998. PMID: 9440724
415 results